Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders-Reference-Cited by-同舟云学术

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders

Published:2013-12-17 Issue:6 Volume:28 Page:1299-1307
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Ladetto M,Brüggemann M,Monitillo L,Ferrero S,Pepin F,Drandi D,Barbero D,Palumbo A,Passera R,Boccadoro M,Ritgen M,Gökbuget N,Zheng J,Carlton V,Trautmann H,Faham M,Pott C

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2013375.pdf

Reference40 articles.

1. Pott C . Minimal residual disease detection in mantle cell lymphoma: technical aspects and clinical relevance. Semin Hematol 2011; 48: 172–184.

2. Ferrero S, Drandi D, Mantoan B, Ghione P, Omedè P, Ladetto M . Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigms. Hematol Oncol 2011; 29: 167–176.

3. Brüggemann M, Gökbuget N, Kneba M . Acute lymphoblastic leukemia: monitoring minimal residual disease as a therapeutic principle. Semin Oncol 2012; 39: 47–57.

4. Brüggemann M, Raff T, l Kneba M . Has MRD monitoring superseded other prognostic factors in adult ALL? Blood 2012; 120: 4470–4481.

5. Campana D . Minimal residual disease monitoring in childhood acute lymphoblastic leukemia. Curr Opin Hematol 2012; 19: 313–318.

Cited by 259 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimal residual disease detection in lymphoma: methods, procedures and clinical significance;Frontiers in Immunology;2024-08-12

2. Evaluation of next-generation sequencing for measurable residual disease monitoring in three major fusion transcript subtypes of B-precursor acute lymphoblastic leukaemia;Pathology;2024-08

3. Advances in estimating plasma cells in bone marrow: A comprehensive method review;African Journal of Laboratory Medicine;2024-07-11

4. Measurable Residual Disease of Multiple Myeloma: Current Methods and Future Directions;Laboratory Medicine Online;2024-07-01

5. Monitoring measurable residual disease in paediatric acute lymphoblastic leukaemia using immunoglobulin gene clonality based on next-generation sequencing;Cancer Cell International;2024-06-25